Literature DB >> 31714960

Do next-generation sequencing results drive diagnostic and therapeutic decisions in MDS?

Felicitas Thol1, Uwe Platzbecker2.   

Abstract

This article has a companion Counterpoint by Sanz et al.
© 2019 by The American Society of Hematology.

Entities:  

Year:  2019        PMID： 31714960      PMCID： PMC6855118          DOI： 10.1182/bloodadvances.2018022434

Source DB:  PubMed          Journal:  Blood Adv        ISSN： 2473-9529


  39 in total

1.  Impact of TET2 mutations on response rate to azacitidine in myelodysplastic syndromes and low blast count acute myeloid leukemias.

Authors:  R Itzykson; O Kosmider; T Cluzeau; V Mansat-De Mas; F Dreyfus; O Beyne-Rauzy; B Quesnel; N Vey; V Gelsi-Boyer; S Raynaud; C Preudhomme; L Adès; P Fenaux; M Fontenay
Journal:  Leukemia       Date:  2011-04-15       Impact factor: 11.528

2.  Genetic characterization of acquired aplastic anemia by targeted sequencing.

Authors:  Michael Heuser; Carola Schlarmann; Vera Dobbernack; Victoria Panagiota; Lutz Wiehlmann; Carolin Walter; Fabian Beier; Patrick Ziegler; Haiyang Yun; Sofia Kade; Aylin Kirchner; Liu Huang; Christian Koenecke; Matthias Eder; Tim H Brümmendorf; Martin Dugas; Arnold Ganser; Felicitas Thol
Journal:  Haematologica       Date:  2014-06-06       Impact factor: 9.941

3.  Systematic STAT3 sequencing in patients with unexplained cytopenias identifies unsuspected large granular lymphocytic leukemia.

Authors:  Elizabeth A Morgan; Mark N Lee; Daniel J DeAngelo; David P Steensma; Richard M Stone; Frank C Kuo; Jon C Aster; Christopher J Gibson; R Coleman Lindsley
Journal:  Blood Adv       Date:  2017-09-13

4.  Luspatercept for the treatment of anaemia in patients with lower-risk myelodysplastic syndromes (PACE-MDS): a multicentre, open-label phase 2 dose-finding study with long-term extension study.

Authors:  Uwe Platzbecker; Ulrich Germing; Katharina S Götze; Philipp Kiewe; Karin Mayer; Jörg Chromik; Markus Radsak; Thomas Wolff; Xiaosha Zhang; Abderrahmane Laadem; Matthew L Sherman; Kenneth M Attie; Aristoteles Giagounidis
Journal:  Lancet Oncol       Date:  2017-09-01       Impact factor: 41.316

5.  Clonal hematopoiesis and blood-cancer risk inferred from blood DNA sequence.

Authors:  Giulio Genovese; Anna K Kähler; Robert E Handsaker; Johan Lindberg; Samuel A Rose; Samuel F Bakhoum; Kimberly Chambert; Eran Mick; Benjamin M Neale; Menachem Fromer; Shaun M Purcell; Oscar Svantesson; Mikael Landén; Martin Höglund; Sören Lehmann; Stacey B Gabriel; Jennifer L Moran; Eric S Lander; Patrick F Sullivan; Pamela Sklar; Henrik Grönberg; Christina M Hultman; Steven A McCarroll
Journal:  N Engl J Med       Date:  2014-11-26       Impact factor: 91.245

6.  IDH1 mutations in patients with myelodysplastic syndromes are associated with an unfavorable prognosis.

Authors:  Felicitas Thol; Eva M Weissinger; Jürgen Krauter; Katharina Wagner; Frederik Damm; Martin Wichmann; Gudrun Göhring; Christiane Schumann; Gesine Bug; Oliver Ottmann; Wolf-Karsten Hofmann; Brigitte Schlegelberger; Arnold Ganser; Michael Heuser
Journal:  Haematologica       Date:  2010-05-21       Impact factor: 9.941

7.  Prognostic Mutations in Myelodysplastic Syndrome after Stem-Cell Transplantation.

Authors:  R Coleman Lindsley; Wael Saber; Brenton G Mar; Robert Redd; Tao Wang; Michael D Haagenson; Peter V Grauman; Zhen-Huan Hu; Stephen R Spellman; Stephanie J Lee; Michael R Verneris; Katharine Hsu; Katharina Fleischhauer; Corey Cutler; Joseph H Antin; Donna Neuberg; Benjamin L Ebert
Journal:  N Engl J Med       Date:  2017-02-09       Impact factor: 91.245

8.  Molecular Minimal Residual Disease in Acute Myeloid Leukemia.

Authors:  Mojca Jongen-Lavrencic; Tim Grob; Diana Hanekamp; François G Kavelaars; Adil Al Hinai; Annelieke Zeilemaker; Claudia A J Erpelinck-Verschueren; Patrycja L Gradowska; Rosa Meijer; Jacqueline Cloos; Bart J Biemond; Carlos Graux; Marinus van Marwijk Kooy; Markus G Manz; Thomas Pabst; Jakob R Passweg; Violaine Havelange; Gert J Ossenkoppele; Mathijs A Sanders; Gerrit J Schuurhuis; Bob Löwenberg; Peter J M Valk
Journal:  N Engl J Med       Date:  2018-03-29       Impact factor: 91.245

9.  TET2 mutations predict response to hypomethylating agents in myelodysplastic syndrome patients.

Authors:  Rafael Bejar; Allegra Lord; Kristen Stevenson; Michal Bar-Natan; Albert Pérez-Ladaga; Jacques Zaneveld; Hui Wang; Bennett Caughey; Petar Stojanov; Gad Getz; Guillermo Garcia-Manero; Hagop Kantarjian; Rui Chen; Richard M Stone; Donna Neuberg; David P Steensma; Benjamin L Ebert
Journal:  Blood       Date:  2014-09-15       Impact factor: 22.113

10.  Evaluation of Patients and Families With Concern for Predispositions to Hematologic Malignancies Within the Hereditary Hematologic Malignancy Clinic (HHMC).

Authors:  Courtney D DiNardo; Sarah A Bannon; Mark Routbort; Anna Franklin; Maureen Mork; Mary Armanios; Emily M Mace; Jordan S Orange; Meselle Jeff-Eke; Jane E Churpek; Koichi Takahashi; Jeffrey L Jorgensen; Guillermo Garcia-Manero; Steve Kornblau; Alison Bertuch; Hannah Cheung; Kapil Bhalla; Andrew Futreal; Lucy A Godley; Keyur P Patel
Journal:  Clin Lymphoma Myeloma Leuk       Date:  2016-04-27
View more
  3 in total

1.  Patient stratification in myelodysplastic syndromes: how a puzzle may become a map.

Authors:  Anne Sophie Kubasch; Uwe Platzbecker
Journal:  Hematology Am Soc Hematol Educ Program       Date:  2020-12-04

2.  Guideline-based indicators for adult patients with myelodysplastic syndromes.

Authors:  Kristina Stojkov; Tobias Silzle; Georg Stussi; David Schwappach; Juerg Bernhard; David Bowen; Jaroslav Čermák; Avinash G Dinmohamed; Corien Eeltink; Sabrina Eggmann; Pierre Fenaux; Ulrich Germing; Manuel Haschke; Eva Hellstrom-Lindberg; Monika Heger; Arjan A van de Loosdrecht; Jakob Passweg; Michael Pfeilstöcker; Uwe Platzbecker; Luca Malcovati; António Medina de Almeida; Moshe Mittelman; Christine Morgenthaler; David P Steensma; Valeria Santini; Reinhard Stauder; Argiris Symeonidis; Sämi Schär; Charlotte Maddox; Theo de Witte; Julia Bohlius; Nicolas Bonadies
Journal:  Blood Adv       Date:  2020-08-25

Review 3.  Persistent Large Granular Lymphocyte Clonal Expansions: "The Root of Many Evils"-And of Some Goodness.

Authors:  Carlos Bravo-Pérez; Salvador Carrillo-Tornel; Esmeralda García-Torralba; Andrés Jerez
Journal:  Cancers (Basel)       Date:  2022-03-05       Impact factor: 6.639
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.